Re-training the nose to change how allergies behave
Part of Ear, nose & throat, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to understand the study and sign informed consent, if you join
- Be age 18 to 60
- Do not have major chronic lung disease other than asthma (for the asthma group)
- Be a non-smoker (or a very limited past smoker, quit at least 5 years ago)
- For allergy groups: have allergy evidence to cat (blood test/skin test) plus regular cat exposure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.
This study looks at how pollen, climate, and air pollution affect people with seasonal allergies (chronic rhinitis). It aims to see if these factors worsen symptoms and could help improve allergy care.
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
This trial tests a treatment called washed microbiota transplantation, which transfers gut bacteria from healthy donors to people with allergic rhinitis. The goal is to see if changing the gut bacteria can reduce allergy symptoms like sneezing, itching, and a runny or blocked nose.
This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.